Back

Novartis could cut about 130 jobs as Basel activities relocate

Verifying
  • Novartis plans to relocate Kleinbasel laboratories and end small-scale biologics production.
  • About 130 Swiss jobs are at risk; roughly 200 people work at Kleinbasel.
  • Novartis says laboratory moves finish by 2028, while production ends by 2027.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.